Medical Developments International Limited (ASX:MVP)

ASX:MVP Revenue

In the fiscal year ending June 30, 2026, Medical Developments International had annual revenue of 42.57M AUD with 8.99% growth. Medical Developments International had revenue of 21.00M in the half year ending June 30, 2026, with 16.22% growth. That makes Medical Developments International the 31,373rd largest company in the world by revenue and 546th in Australia.

• Revenue: 42.57M
• Revenue Growth: +8.99%
• P/S Ratio: 1.06
• Revenue / Employee: 626.00K
• Employees: 68
• Market Cap: 43.94M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pain Management 31.62M 74.3%
• Respiratory 10.95M 25.7%

By Geography

Chart

• Australia 20.87M 49.0%
• Europe 9.61M 22.6%
• United States 6.14M 14.4%
• Rest of The World 5.95M 14.0%

Fiscal year ended Jun 30, 2026 See the full ASX:MVP breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	42.57M	3.51M	8.99%
Jun 30, 2025	39.06M	5.91M	17.82%
Jun 30, 2024	33.15M	812.00K	2.51%
Jun 30, 2023	32.34M	10.39M	47.37%
Jun 30, 2022	21.94M	-3.33M	-13.17%

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error